Composition, form of production and packaging
? Drops for ingestion 100 ml
adonidide 30.3 ml
liquid extract of hawthorn 2.2 ml
tincture of valerian 48.6 ml
liquid extract of a herb of icteric 17.2 ml
camphor racemic 400 mg
sodium bromide 2 g
15 ml - a bottle of a dropper of dark glass (1) - packs cardboard.
25 ml - a bottle of a dropper of dark glass (1) - packs cardboard.
50 ml - a bottle of a dropper of dark glass (1) - packs cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2011.
The drug has sedative, as well as spasmolytic and moderate cardiotonic action.
- as a sedative in the complex therapy of functional disorders of the cardiovascular system, cardialgia, climacteric syndrome, increased nervous excitability, sleep disturbances.
The drug is administered orally 10-20 drops 3-4 times / day, 30 minutes before meals. If necessary, you can increase the dose to 30 drops. The course of treatment is 20-30 days. Conducting repeated courses of treatment is possible in agreement with the doctor.
Possible allergic reactions, drowsiness, decreased efficiency. In rare cases, development of dyspeptic disorders is possible.
- arterial hypotension;
- Decrease in heart rate (less than 55 beats per minute);
- lactation period;
- age up to 18 years;
- Hypersensitivity to the components of the drug.
With caution: liver disease, alcoholism, epilepsy, craniocerebral trauma, brain disease.
PREGNANCY AND LACTATION
Contraindicated in pregnancy and lactation.
APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS
With caution: liver disease.
APPLICATION FOR CHILDREN
Contraindicated in children under 18 years.
The composition of the drug contains at least 64% of ethyl alcohol. The maximum daily dose of the drug (120 drops = 2.35 ml) contains 1.3 g of ethanol.
Impact on the ability to drive vehicles and manage mechanisms.
When using the drug, it is possible to reduce the concentration and speed of psychomotor reactions, therefore, it should not be used in potentially dangerous activities (driving vehicles, working with mechanisms, etc.), requiring concentration of attention and speed of mental and motor reactions. The drug is not intended for arresting attacks of cardialgia.
With prolonged use of the drug in doses exceeding the recommended, it is possible to increase the severity of such side effects as drowsiness, decreased efficiency, dyspeptic disorders.
With the simultaneous use of the drug Kravaleon with drugs that depress the central nervous system (sedatives, hypnotics, tranquilizers, neuroleptics), there may be a mutual enhancement of effects.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
Keep the drug in a dark place at a temperature of 15 В° to 25 В° C. Keep out of the reach of children.
Shelf-life is 2 years.
Do not use after the expiration date printed on the package.